Oliver Freudenreich, M.D.
Associate Professor of Psychiatry
Harvard Medical School
Medical Director, Schizophrenia Program
Director, Early Psychosis Program/Schizophrenia Fellowship
Massachusetts General Hospital
Dr. Freudenreich is Associate Professor at Harvard Medical School and Medical Director of the Schizophrenia Program, Director of the Early Psychosis Program, and Director of the Schizophrenia Fellowship at Massachusetts General Hospital in Boston.
Dr. Freudenreich received his medical degree from the University of Heidelberg in Germany. He completed his psychiatric residency at the University of Medicine and Dentistry of New Jersey. Additional training included a two-year fellowship at Duke University in psychiatric research and a one-year fellowship at MGH in Consultation Psychiatry.
For his involvement in research and teaching, Dr. Freudenreich has received fellowships from the Society of Biological Psychiatry, the Academy of Psychosomatic Medicine, and the American Association of Directors of Psychiatric Residency Training. He was thrice named “Teacher of the Year” in the Department of Psychiatry at Boston University.
With a primary interest in the optimal treatment of schizophrenia, Dr. Freudenreich has focused on both first- and multi-episode patients. He has published articles, reviews, editorials, and book chapters in his areas of expertise. He has also written a book on psychotic disorders published by Lippincott Williams & Wilkins. Dr. Freudenreich received support from the Stanley Foundation for his research.
Dr. Freudenreich also directs the Infectious Disease Psychiatric Consultation Service in the MGH Division of Psychiatry and Medicine. This service provides evaluation and treatment to patients seen in the MGH Infectious Disease Clinic, many of whom are diagnosed with HIV/AIDS.